Description: RepliCel Life Sciences Inc. (RepliCel), formerly Newcastle Resources Ltd. is a Canada-based company, engaged in the business of developing and patenting hair follicle cell replication technology. The Company’s cellular replication and implantation technology is designed to rejuvenate damaged, miniaturized hair follicles in balding scalp skin. The Company is developing an autologous cell-based procedure for the treatment of androgenetic alopecia (pattern baldness) and general hair loss in men and women. It is focused on ensuring the safety and demonstrating the efficacy of RepliCel’s cell-based hair regeneration procedure in humans. As of September 30, 2012, the Company‘s subsidiary included TrichoScience Innovations Inc. (TrichoScience).
Home Page: www.replicel.com
570 Granville Street
Vancouver,
BC
V6C 3P1
Canada
Phone:
604 248 8730
Officers
| Name | Title |
|---|---|
| Mr. Andrew Schutte | Pres, CEO & Director |
| Dr. Kevin John McElwee Ph.D. | Co-Founder & Chief Scientific Officer |
| Mr. Simon S. Ma B.A., CPA, CA | Chief Financial Officer |
| Dr. Rolf Hoffmann M.D. | Chief Medical Officer & Member of Clinical Advisory Board |
| Mr. R. Lee Buckler B.Ed., L.L.B., LLB | Corp. Sec. & Director |
| Ben Austring | Chief Legal Officer & Operations Mang. |
| Mr. Darrell Panich M.Sc, PMP, CPM | Clinical Consultant |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 8.3521 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |